| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | WO2001082953A8 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 04/29/2004 | WO2001079274A8 Tuberculosis antigens and methods of use thereof |
| 04/29/2004 | WO1994004185A3 Method of inhibiting reduction of disulfide bonds |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040083498 Cloning method using oocytes matured in vivo |
| 04/29/2004 | US20040083497 Genetic engineering; induct immunology response using antibodies |
| 04/29/2004 | US20040083496 Genetic engineered polypeptides; incubation, amplification |
| 04/29/2004 | US20040082937 Method and device for the controlled delivery of parathyroid hormone |
| 04/29/2004 | US20040082934 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082771 Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof |
| 04/29/2004 | US20040082765 Immobilization; sustained release |
| 04/29/2004 | US20040082761 Cell adhesion proteins |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082757 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
| 04/29/2004 | US20040082659 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| 04/29/2004 | US20040082643 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082574 Compounds with the bicyclo[4.2.1]nonane system for the treatment of flavivridae infections |
| 04/29/2004 | US20040082557 Methods for treating estrogen-dependent disorders |
| 04/29/2004 | US20040082534 Treatment of melanoma by reduction in clusterin levels |
| 04/29/2004 | US20040082518 Antiinflammatory/coagulant prodrug |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082516 For in vitro/vivo drugs; neuropathy |
| 04/29/2004 | US20040082514 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | US20040082512 Drugs for treatment of inflammation/blood brain barrier degradation |
| 04/29/2004 | US20040082511 Drug composition for the promotion of tissue regeneration |
| 04/29/2004 | US20040082510 Pyk2 phosphorylation by her3 induces tumor invasion |
| 04/29/2004 | US20040082509 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082506 For treating hypophosphatemic rickets/osteomalacia/ osteoporosis/renal osteodystrophy/dialysis-associated bone diseases |
| 04/29/2004 | US20040082505 Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia |
| 04/29/2004 | US20040082504 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 04/29/2004 | US20040082503 Comprises substituted human insulin B chain; drugs |
| 04/29/2004 | US20040082502 Method for treating wounds to promote healing |
| 04/29/2004 | US20040082501 Compounds and method for the prevention and treatment of diabetic retinopathy |
| 04/29/2004 | US20040082054 Novel depsipeptide compound |
| 04/29/2004 | US20040082039 Immunoglobulin fusion proteins |
| 04/29/2004 | US20040082038 Controlling cell proliferation, cell differentiation; genetic engineering |
| 04/29/2004 | US20040082037 Antiproliferative agents of vascular smooth muscles |
| 04/29/2004 | US20040082030 Angiogenesis factor diseases; antiproliferative agents |
| 04/29/2004 | US20040082026 Viricides; heptatis virus; complexing of interferon with glycan |
| 04/29/2004 | US20040082014 Method and test system for identifying substances which protect nerve cells |
| 04/29/2004 | US20040082007 Genetic engineering of isolated nucleic acids; pain therapy; central nervous system disorders; inserting plasmids; hybridization |
| 04/29/2004 | US20040082003 Stem cell expansion enhancing factor and method of use |
| 04/29/2004 | US20040082002 Genetic engineering; screening antagonist; medical diagnosis using antibodies |
| 04/29/2004 | US20040081999 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081992 Controlling gene expression; cell differentiation; drug screening; complexing, measuring binding |
| 04/29/2004 | US20040081984 Ocular tear growth factor-like protein |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081970 Isolated nucleic acids; antibody for selective binding |
| 04/29/2004 | US20040081961 Genetic engineering; therapy, diagnosis of disease; gastrointestinal, cardiovascular diseases; autoimmune disease; antiinflammatory agents; central nervous system disorders; antitumor, anticancer agents |
| 04/29/2004 | US20040081955 Animal extract from earthworm; contraceptive; side effect reduction |
| 04/29/2004 | US20040081714 Cosmetic and/or pharmaceutical preparations |
| 04/29/2004 | US20040081688 Comprising a drug, a lipid matrix and a surfactant characterized in that said drug is a peptide or a protein and lipid matrix has a monoglyceride content which is at least 70% w/w |
| 04/29/2004 | US20040081686 Use of particle vectors in immunomodulation |
| 04/29/2004 | US20040081673 Compositions and methods for the treatment of skin damage |
| 04/29/2004 | US20040081660 Polypeptide and protein derivatives and process for their preparation |
| 04/29/2004 | US20040081659 Conjugates useful in the treatment of prostate cancer |
| 04/29/2004 | US20040081658 Epitopes involved in the immune response to human papillomavirus; induction and/or enhancement of a T cell response directed towards an antigen, using peptides comprising specific epitopes for said antigen |
| 04/29/2004 | US20040081657 Prevention and treatment of amyloidogenic disease |
| 04/29/2004 | US20040081653 Aberrantly over-expressed in at least some cancers, such as prostate and bladder cancers |
| 04/29/2004 | US20040081652 Administering an isolated molecule comprising an antibody variable region which specifically binds to a neuronal marker protein whereby neuronal cell death in the mammal is inhibited or prevented |
| 04/29/2004 | US20040081650 Inflammatory mediator antagonists |
| 04/29/2004 | US20040081649 Treating Atopic dermatitis with IgE antagonists |
| 04/29/2004 | US20040081648 Adzymes and uses thereof |
| 04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
| 04/29/2004 | US20040081646 Group B Streptococcal phage lysin |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | US20040081640 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 04/29/2004 | US20040081638 Delivery of disease control in aquaculture and agriculture using nutritional feeds containing bioactive proteins produced by viruses |
| 04/29/2004 | US20040081635 Antiinflammatory agents; anticancer agents; bactericides; fungicides; autoimmune diseases; mixture of interferons with carriers |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2851113A1 Methods and compositions for improving growth of meat-type poultry |
| 04/29/2004 | CA2649821A1 Polynucleotide sequences encoding .delta.bcl-2 for preventing and treating autoimmune diseases |
| 04/29/2004 | CA2542620A1 Method of treating snoring and other obstructive breathing disorders |
| 04/29/2004 | CA2542513A1 Treatment of osteoarthritis |
| 04/29/2004 | CA2542510A1 Treatment of hypersensitivity conditions |
| 04/29/2004 | CA2542507A1 Treatment of inflammatory bowel disease |
| 04/29/2004 | CA2503325A1 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | CA2502794A1 Composition for reducing caloric intake |
| 04/29/2004 | CA2502539A1 Protein modification |
| 04/29/2004 | CA2502510A1 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor |
| 04/29/2004 | CA2502357A1 Susceptibility gene for myocardial infarction; methods of treatment |
| 04/29/2004 | CA2502324A1 Glucagon - like peptide - 2 variants |
| 04/29/2004 | CA2502257A1 A method of modulating endothelial cell activity by modulating the functional levels level of sphingosine kinase |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/29/2004 | CA2501994A1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 04/29/2004 | CA2501943A1 Orally administered peptides synergize statin activity |
| 04/29/2004 | CA2501856A1 Botulinum toxin dental therapies and procedures |
| 04/29/2004 | CA2501333A1 Factor involved in metastasis and uses thereof |
| 04/29/2004 | CA2501298A1 Method of modifying the release profile of sustained release compositions |
| 04/29/2004 | CA2500653A1 Glycoprotein synthesis |
| 04/29/2004 | CA2500336A1 Improved immunotherapy |
| 04/29/2004 | CA2500295A1 Stabilized exendin-4 compounds |